Exodos Life Sciences

Exodos Life Sciences is a San Diego-based biotechnology company focused on developing first-in-class small molecule therapeutics for neurodegenerative and neuroinflammatory diseases. The company's core technology centers on the "Exodos" pathway, a newly discovered cellular mechanism involved in the regulation of protein secretion and the response to cellular stress. By modulating this pathway, Exodos aims to address the underlying proteotoxicity and inflammation that drive diseases such as Alzheimer's and Amyotrophic Lateral Sclerosis (ALS). Currently in the pre-clinical stage, the company leverages its proprietary platform to identify high-affinity compounds with optimal blood-brain barrier penetration to restore cellular homeostasis.